Precision BioSciences, Inc. (DTIL)
7.27
-0.84
(-10.36%)
USD |
NASDAQ |
May 15, 16:00
7.31
+0.04
(+0.55%)
After-Hours: 20:00
Precision BioSciences EPS Diluted (Quarterly) : -0.7486 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 0.1236 |
| Cartesian Therapeutics, Inc. | -1.459 |
| AnaptysBio, Inc. | -1.843 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.44M |
| Revenue (Quarterly) | 10.84M |
| Total Expenses (Quarterly) | 29.28M |
| Enterprise Value | 114.89M |
| Gross Profit Margin (Quarterly) | 94.09% |
| Profit Margin (Quarterly) | -170.2% |
| Earnings Yield | -51.11% |
| Normalized Earnings Yield | -50.79 |